Compare CRL & UMBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRL | UMBF |
|---|---|---|
| Founded | 1947 | 1913 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 8.8B |
| IPO Year | 1999 | 2006 |
| Metric | CRL | UMBF |
|---|---|---|
| Price | $149.57 | $126.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 10 |
| Target Price | ★ $198.27 | $138.90 |
| AVG Volume (30 Days) | ★ 736.3K | 704.8K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.39% |
| EPS Growth | N/A | ★ 3.34 |
| EPS | N/A | ★ 3.35 |
| Revenue | ★ $1,857,601,000.00 | N/A |
| Revenue This Year | N/A | $18.07 |
| Revenue Next Year | $3.04 | $6.85 |
| P/E Ratio | ★ N/A | $37.14 |
| Revenue Growth | ★ 10.48 | N/A |
| 52 Week Low | $132.58 | $98.22 |
| 52 Week High | $228.88 | $136.11 |
| Indicator | CRL | UMBF |
|---|---|---|
| Relative Strength Index (RSI) | 33.06 | 53.78 |
| Support Level | $147.22 | $116.18 |
| Resistance Level | $184.75 | $135.39 |
| Average True Range (ATR) | 8.35 | 3.41 |
| MACD | -2.91 | -0.75 |
| Stochastic Oscillator | 1.44 | 38.64 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
UMB Financial Corp, or UMBF, is a financial services holding company offering a suite of banking services and asset servicing to its customers in the United States and around the world. Its client base includes commercial, institutional, and personal customers. Along with its subsidiaries, the company operates in the following business segments: Commercial Banking, Institutional Banking, and Personal Banking. A majority of its revenue is generated from the Commercial Banking segment, which serves the commercial banking and treasury management needs of small to middle-market businesses through various products and services such as commercial loans, commercial real estate financing, commercial credit cards, letters of credit, loan syndication services, consultative services, and others.